Navellier & Associates’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-3,660
| Closed | -$505K | – | 347 |
|
|
2023
Q4 | $505K | Buy |
3,660
+904
| +33% | +$125K | 0.08% | 221 |
|
|
2023
Q3 | $336K | Buy |
2,756
+217
| +9% | +$26.4K | 0.06% | 246 |
|
|
2023
Q2 | $357K | Buy |
2,539
+412
| +19% | +$57.9K | 0.07% | 207 |
|
|
2023
Q1 | $301K | Buy |
2,127
+116
| +6% | +$16.4K | 0.06% | 220 |
|
|
2022
Q4 | $315K | Sell |
2,011
-9
| -0.4% | -$1.41K | 0.06% | 211 |
|
|
2022
Q3 | $248K | Sell |
2,020
-34
| -2% | -$4.17K | 0.06% | 235 |
|
|
2022
Q2 | $273K | Hold |
2,054
| – | – | 0.06% | 241 |
|
|
2022
Q1 | $281K | Buy |
2,054
+53
| +3% | +$7.25K | 0.05% | 256 |
|
|
2021
Q4 | $346K | Sell |
2,001
-7
| -0.3% | -$1.21K | 0.05% | 252 |
|
|
2021
Q3 | $292K | Hold |
2,008
| – | – | 0.04% | 266 |
|
|
2021
Q2 | $265K | Sell |
2,008
-11
| -0.5% | -$1.45K | 0.04% | 256 |
|
|
2021
Q1 | $259K | Sell |
2,019
-12
| -0.6% | -$1.54K | 0.05% | 250 |
|
|
2020
Q4 | $242K | Buy |
+2,031
| New | +$242K | 0.04% | 249 |
|